AIM WINNERS & LOSERS: Immunodiagnostic surges on PerkinElmer takeover

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on ...

Alliance News 17 May, 2021 | 11:15AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.




Immunodiagnostic Systems Holdings PLC, up 41% at 360.00 pence, 12-month range 180.00p-420.00p. The diagnostic solutions provider agrees to an all-cash takeover offer from the UK arm of Waltham, Massachusetts-based PerkinElmer Inc. The offer of 382p per share is a 44% premium to Friday's closing price of 265.00p. It values the share capital of Immunodiagnostic Systems at GBP110 million and implies an enterprise value of GBP88 million, the two companies note.


MyHealthChecked PLC, up 19% at 5.00p, 12-month range 0.71p-7.45p. The home-testing healthcare company says it has signed a second contract with pharmaceutical and beauty retailer Boots UK Ltd for its at-home Covid-19 nasal swab kit, extending its offering to include tests for international arrivals to the UK.


Cerillion PLC, up 9.2% at 666.00p, 12-month range 250.00p-670.00p. The billing and customer relations management software firm hails a "record" interim performance as orders surged, with the company boosting its payout by a fifth. New orders amount to GBP23.6 million in the half-year ended March 31, jumping from GBP9.5 million a year ago, which led to a 26% increase in revenue to GBP12.8 million from GBP10.2 million. Pretax profit more than doubles to GBP3.3 million from GBP1.2 million year-on-year. The company boosts its interim payout by 20% to 2.10 pence from 1.75p a year ago.


Rotala PLC, up 3.9% at 35.32p, 12-month range 18.00p-37.00p. The West Midlands-based bus service operator says it welcomes the UK government's promise to invest GBP3 billion in buses and "intends to be a keen participant" in the plans. The government on Monday published further details on its national bus strategy for England, emphasising the need for local authorities and bus operators to build on their close relationships formed during the pandemic, Rotala says.




W Resources PLC, down 13% at 8.08p, 12-month range 7.66p-27.40p. The tungsten, tin and gold mining company says it has completed a placing to raise GBP2.3 million, which will be expanded to GBP2.5 million when Chair Michael Masterman invests. Place 28.3 million shares at 8 pence each to raise GBP2.3 million from new and existing investors. Masterman intends to participate and invest GBP250,000 on the same terms as the placing once the company has published its 2020 accounts and is no longer in a closed period. This will bump up the fundraising to GBP2.5 million.


Blue Prism Group PLC, down 5.3% at 1,020.00p, 12-month range 1,100.00p-1,900.00p. The robotic process automation firm says it expects full-year revenue to be towards the lower end of guidance. Closing annual recurring revenue was GBP168 million compared to GBP154 million for the year to October 31, 2020. Based on the first-half annual recurring revenue runrate, and prevailing foreign exchange rates, the company believes full-year revenue is likely to be towards the lower end of the GBP170 million to GBP180 million guidance range.


By Arvind Bhunjun;

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Cerillion PLC 860.00 GBX 0.00 -
Blue Prism Group PLC 821.50 GBX 6.83 -
Immunodiagnostic Systems Holdings PLC 378.00 GBX 0.00 -
MyHealthChecked PLC 2.90 GBX -1.69 -
Rotala PLC 30.50 GBX 0.00 -
W Resources PLC 7.55 GBX -1.31 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation

By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement